General Information of the Protein
Protein ID
PT03632
Protein Name
Sigma intracellular receptor 2
Secondarily
Protein Name
Meningioma-associated protein 30
Transmembrane protein 97
Gene Name
TMEM97
Secondarily
Gene Name
MAC30
S2R
Sequence
MGAPATRRCVEWLLGLYFLSHIPITLFMDLQAVLPRELYPVEFRNLLKWYAKEFKDPLLQEPPAWFKSFLFCELVFQLPFFPIATYAFLKGSCKWIRTPAIIYSVHTMTTLIPILSTFLFEDFSKASGFKGQRPETLHERLTLVSVYAPYLLIPFILLIFMLRSPYYKYEEKRKKK
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Membrane receptor
Function
Intracellular sigma-2 receptor that binds histatin 1/HN1 (Hst 1) at the endoplasmic reticulun (ER) membrane, which is critical for mitochondrial-targeting and -activating properties of Hst1 (PubMed:34233061, PubMed:35970844). Thought to play important role in regulating cell survival, morphology and differentiation (PubMed:23922215, PubMed:25620095). May play a role as a regulator of cellular cholesterol homeostasis (PubMed:19583955). May function as sterol isomerase (PubMed:25566323). May alter the activity of some cytochrome P450 proteins (PubMed:22292588).
    Show/Hide
Uniprot ID
Primary ID:
Q5BJF2

Secondarily ID:
B4DS02
Q07823
    Show/Hide
Ensembl ID
ENSG00000109084
HGNC ID
HGNC:28106
Subcellular Location
Nucleus membrane
Rough endoplasmic reticulum membrane
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000025 , HEK-293T
Compound ID Compound Name Compound Formula
CP0426385
(3aS,9bS)-3a-methyl-8-phenyl-2,3,4,9b-tetrahydro-1H-chromeno[3,4-b]pyrrole
   Show/Hide
C18H19NO
 1
1
Ki = 79.43 nM
   TI
   LI
   LO
   TS
CP0432125
(3aS,9bS)-8-bromo-5-(4-bromophenyl)-3a-methyl-2,3,4,9b-tetrahydro-1H-pyrrolo[2,3-c]quinoline
   Show/Hide
C18H18Br2N2
 1
1
Ki = 79.43 nM
   TI
   LI
   LO
   TS
CP0391127
(3aS,9bS)-3a-methyl-7-phenylmethoxy-2,3,4,9b-tetrahydro-1H-chromeno[3,4-b]pyrrole
   Show/Hide
C19H21NO2
 1
1
Ki = 100 nM
   TI
   LI
   LO
   TS
CP0426383
(3aS,9bS)-3a-methyl-6-phenyl-2,3,4,9b-tetrahydro-1H-chromeno[3,4-b]pyrrole
   Show/Hide
C18H19NO
 1
1
Ki = 125.89 nM
   TI
   LI
   LO
   TS
CP0391130
(3aS,9bS)-3,3a-dimethyl-5-phenyl-1,2,4,9b-tetrahydropyrrolo[2,3-c]quinoline
   Show/Hide
C19H22N2
 1
1
Ki = 158.49 nM
   TI
   LI
   LO
   TS
CP0426378
(3aS,9bS)-3,3a-dimethyl-6-phenyl-1,2,4,9b-tetrahydrochromeno[3,4-b]pyrrole
   Show/Hide
C19H21NO
 1
1
Ki = 316.23 nM
   TI
   LI
   LO
   TS
CP0426382
(3aS,9bS)-3a,7,9-trimethyl-2,3,4,9b-tetrahydro-1H-chromeno[3,4-b]pyrrole
   Show/Hide
C14H19NO
 1
1
Ki = 316.23 nM
   TI
   LI
   LO
   TS
CP0426405
(3aS,9bS)-3a,8-dimethyl-5-(4-methylphenyl)-2,3,4,9b-tetrahydro-1H-pyrrolo[2,3-c]quinoline
   Show/Hide
C20H24N2
 1
1
Ki = 316.23 nM
   TI
   LI
   LO
   TS
CP0437998
(3S,4S)-4-ethyl-3-methyl-6-phenyl-2,4-dihydrochromen-3-amine
   Show/Hide
C18H21NO
 1
1
Ki = 316.23 nM
   TI
   LI
   LO
   TS
CP0455600
(3S,4S)-4-ethyl-3-methyl-2,4-dihydrobenzo[h]chromen-3-amine
   Show/Hide
C16H19NO
 1
1
Ki = 316.23 nM
   TI
   LI
   LO
   TS
CP0411059
(3S,4S)-4-ethyl-3-methyl-1-phenyl-2,4-dihydroquinolin-3-amine
   Show/Hide
C18H22N2
 1
1
Ki = 630.96 nM
   TI
   LI
   LO
   TS
CP0426384
(3aS,9bS)-6-bromo-3a-methyl-2,3,4,9b-tetrahydro-1H-chromeno[3,4-b]pyrrole
   Show/Hide
C12H14BrNO
 1
1
Ki = 630.96 nM
   TI
   LI
   LO
   TS
CP0387083
(3aS,9bS)-3a-methyl-5-phenyl-2,3,4,9b-tetrahydro-1H-pyrrolo[2,3-c]quinoline
   Show/Hide
C18H20N2
 1
1
Ki = 1000 nM
   TI
   LI
   LO
   TS
CP0455607
(3aS,9bS)-3a-methyl-2,3,4,9b-tetrahydro-1H-chromeno[3,4-b]pyrrol-7-ol
   Show/Hide
C12H15NO2
 1
1
Ki = 1000 nM
   TI
   LI
   LO
   TS
CP0117807
4-[4-[1-[4-[1-(6-aminohexyl)triazol-4-yl]butyl]piperidin-4-yl]phenyl]-7-[4-(trifluoromethyl)phenyl]naphthalene-2-carboxylic acid
   Show/Hide
C41H46F3N5O2
 1
1
Ki = 1200 nM
   TI
   LI
   LO
   TS
CP0391128
1-[(3aS,9bS)-3a-methyl-6-phenyl-1,2,4,9b-tetrahydrochromeno[3,4-b]pyrrol-3-yl]ethanone
   Show/Hide
C20H21NO2
 1
1
Ki = 1258.93 nM
   TI
   LI
   LO
   TS
CP0432102
1-[(3aS,9bS)-3a-methyl-5-phenyl-1,2,4,9b-tetrahydropyrrolo[2,3-c]quinolin-3-yl]ethanone
   Show/Hide
C20H22N2O
 1
1
Ki = 1258.93 nM
   TI
   LI
   LO
   TS
CP0426421
(1S,2S)-1-ethyl-2-methyl-1,3-dihydrobenzo[f]chromen-2-amine
   Show/Hide
C16H19NO
 1
1
Ki = 1995.26 nM
   TI
   LI
   LO
   TS
CP0426380
(3aS,9bS)-8-methoxy-3a-methyl-2,3,4,9b-tetrahydro-1H-chromeno[3,4-b]pyrrole
   Show/Hide
C13H17NO2
 1
1
Ki = 3162.28 nM
   TI
   LI
   LO
   TS
CP0426381
(3aS,9bS)-3,3a-dimethyl-1,2,4,9b-tetrahydrochromeno[3,4-b]pyrrol-7-ol
   Show/Hide
C13H17NO2
 1
1
Ki = 3981.07 nM
   TI
   LI
   LO
   TS
CP0391120
(1S,2R)-1-ethyl-7-methoxy-2-methyl-3,4-dihydro-1H-naphthalen-2-amine
   Show/Hide
C14H21NO
 1
1
Ki > 10000 nM
   TI
   LI
   LO
   TS
CP0391121
(3S,4S)-4-ethyl-3,6-dimethyl-2,4-dihydrochromen-3-amine
   Show/Hide
C13H19NO
 1
1
Ki > 10000 nM
   TI
   LI
   LO
   TS
CP0391154
(3aS,9bS)-7,9-dimethoxy-3a-methyl-2,3,4,9b-tetrahydro-1H-chromeno[3,4-b]pyrrole
   Show/Hide
C14H19NO3
 1
1
Ki > 10000 nM
   TI
   LI
   LO
   TS
CP0416007
(3S,4S)-3-amino-4-ethyl-3-methyl-2,4-dihydrochromen-7-ol
   Show/Hide
C12H17NO2
 1
1
Ki > 10000 nM
   TI
   LI
   LO
   TS
CP0421273
(3S,4S)-4-ethyl-6-methoxy-3-methyl-2,4-dihydrochromen-3-amine
   Show/Hide
C13H19NO2
 1
1
Ki > 10000 nM
   TI
   LI
   LO
   TS
CP0432122
1-[(3aS,9bS)-7-hydroxy-3a-methyl-1,2,4,9b-tetrahydrochromeno[3,4-b]pyrrol-3-yl]ethanone
   Show/Hide
C14H17NO3
 1
1
Ki > 10000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0013421
CAS_97-39-2
   Show/Hide
C15H17N3
 2
1 Ki = 18 nM
2 Ki = 28.4 nM
Clinical Information about the Protein
Target 1 ( Sigma intracellular receptor 2 (TMEM97) )
Target Type Clinical trial Target
Disease 1 Target-related Disease  1
1 Alzheimer disease [ICD-11: 8A20]
Clinical Trial Drug(s) 1 Clinical Trial Drug  1
1 CT1812 Phase 2
Alzheimer disease
Target 2 ( HUMAN sigma intracellular receptor 2 (TMEM97) )
Target Type Unknown Type Target
Disease 2 Target-related Diseases  2
1 Schizophrenia [ICD-11: 6A20]
2 Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y]
Investigative Drug(s) 2 Investigative Drugs  2
1 Haloperidol Approved
Schizophrenia
2 PB28 Investigative
Coronavirus Disease 2019 (COVID-19)